Journals / Turkish Journal of Biology / 2016 / Cilt: 40 - Sayı: 6

Cytotoxic effects of peanut phenolic compounds possessing histone deacetylase inhibitory activity on human colon cancer cell lines

Pages
1258–1271
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Previous results demonstrated that peanut testa extract inhibited both histone deacetylase (HDAC) activity and the growth of colon cancer cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Phenolic compounds present in our diet play an important role in colon cancer chemoprevention.
📊
Key Findings & Data:Previous results demonstrated that peanut testa extract inhibited both histone deacetylase (HDAC) activity and the growth of colon cancer cells.
💡
Conclusion & Impact:These results suggest that these peanut phenolics may be potential antineoplastic agents for colon cancer chemoprevention/chemotherapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Phenolic compounds present in our diet play an important role in colon cancer chemoprevention. Previous results demonstrated that peanut testa extract inhibited both histone deacetylase (HDAC) activity and the growth of colon cancer cells. In this study, four identified phenolic compounds in peanut testae (resveratrol, p-coumaric acid, ferulic acid, and sinapinic acid) were investigated for their HDAC inhibitory and anticancer activities against colon cancer cell lines. In vitro study revealed that resveratrol exhibited the greatest HDAC inhibitory activity. Molecular docking studies demonstrated that all four compounds could bind both HDAC1 and HDAC2. Resveratrol exhibited the most effective antiproliferative activity against both human colon adenocarcinoma (HT29) and human colorectal carcinoma (HCT116) cells. Apoptosis induction by ferulic acid and resveratrol appeared to be associated with p53 activation in HCT116 cells. However, resveratrol, p-coumaric acid, ferulic acid, and sinapinic acid induced apoptosis of HT29 cells in a p53-independent manner. Low-concentration treatments of p-coumaric and ferulic acids resulted in cell cycle arrest of HCT116 cells. In contrast, high-concentration treatments of p-coumaric and ferulic acids showed cell death activation as evidenced by increased sub-G1 fractions. The induction of p21 by p-coumaric acid and resveratrol correlated well with the decreased CDK4 levels and cell cycle arrest. Resveratrol, p-coumaric acid, ferulic acid, and sinapinic acid caused activation of pERK1/2 in HCT116 cells, whereas ferulic and sinapinic acids caused downregulation of pERK1/2 in HT29 cells. These results suggest that these peanut phenolics may be potential antineoplastic agents for colon cancer chemoprevention/chemotherapy.

🔖

Cite This Article

JOGOLOY, S., SENAWONG, T., SANGLEE, S., PATANOTHAI, A. (2022). Cytotoxic effects of peanut phenolic compounds possessing histone deacetylase inhibitory activity on human colon cancer cell lines. Turkish Journal of Biology, Cilt: 40 - Sayı: 6, 1258–1271. https://ajindex.com/articles/600373

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Agrawal S, Agarwal ML, Chatterjee-Kishore M, Stark GR, Chisolm GM (2002). Stat1-dependent, p53-independent expression of p21waf1 modulates oxysterol-induced apoptosis. Mol Cell Biol 22: 1981-1992.
  2. Arai K, Lee SR, van Leyen K, Kurose H, Lo EH (2004). Involvement of ERK MAP kinase in endoplasmic reticulum stress in SHSY5Y human neuroblastoma cells. J Neurochem 89: 232-239.
  3. Asgar A, Senawong G, Sripa B, Senawong T (2016). Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines. Int J Oncol 48: 409-420.
  4. Bagriacik EU, Uslu K, Yurtcu E, Stefek M, Karasu C (2007). Stobadine inhibits doxorubicin-induced apoptosis through a caspase-9 dependent pathway in P815 mastocytoma cells. Cell Biol Int 31: 979-984.
  5. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Ziv Y (1998). Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677.
  6. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, FernandezSalguero PM, Castellon EA (2007). Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 28: 282-293.
  7. Center MM, Jemal A, Smith RA, Ward E (2009). Worldwide variations in colorectal cancer. CA Cancer J Clin 59: 366-378.
  8. Chang JC, Lai YH, Djoko B, Wu PL, Liu CD, Liu YW, Chiou RY (2006). Biosynthesis enhancement and antioxidant and antiinflammatory activities of peanut (Arachis hypogaea L.) arachidin-1, arachidin-3, and isopentadienylresveratrol. J Agric Food Chem 54: 10281-10287.
  9. Cho JW, Jeong YW, Kim KS, Oh JY, Park JC, Lee JC, Suh MH (2001). p21WAF1 is associated with CDK2 and CDK4 protein during HL-60 cell differentiation by TPA treatment. Cell Prolif 34: 267-274.
  10. Dhillon AS, Hagan S, Rath O, Kolch W (2007). MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290.
  11. Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC (2005). Clinical development of histone deacetylase inhibitors as anticancer agents. Ann Rev Pharmacol Toxicol 45: 495-528.
  12. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Ries LA (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116: 544-573.
  13. Gartel AL (2005). The conflicting roles of the cdk inhibitor p21(CIP1/ WAF1) in apoptosis. Leuk Res 29: 1237-1238.
  14. Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Aye